Back

CRT-P vs CRT-D in non-ischemic cardiomyopathy: still a matter of debate

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - treatment (2) Cardiac Resynchronisation Therapy (CRT) HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Marta Bernardo

Hospital Center of Tras-os-Montes and Alto Douro, Vila Real (Portugal)

6 More presentations in this session

Presentation thumbnail
Impact of optimized medical therapy on ICD shocks and survival in heart failure patients
Doctor P. Bernardes (Setubal, PT)
Abstract Slides Video
Presentation thumbnail
Evaluating superresponse in CRT: a clinical edge or just a remodeling effect?
Doctor S. Andraz (Faro, PT)
Abstract Slides Video
Presentation thumbnail
Alert rate characteristics of a dynamic multiparameter heart failure risk score in a real-world cohort: results from the TriageHF Post Approval Study
Doctor C. Love (Baltimore, US)
Abstract Slides Video
Presentation thumbnail
The additional value of sacubitril/valsartan in fusion pacing CRT
Doctor A. Faur (Timisoara, RO)
Abstract Slides Video
Presentation thumbnail
home-based digital cardiac rehabilitation following step down from the acute heart failure virtual ward
Doctor R. Sankaranarayanan (Liverpool, GB)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - treatment (2)

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Systematic review and meta-analysis comparing cardiac resynchronization therapy with versus without defibrillation in patients with non-ischemic cardiomyopathy
thumbnail
Congress Presentation
Long-term outcomes of resynchronization therapy in heart failure patients with ischemic and non-ischemic cardiomyopathy. Single-centre experience.
thumbnail
Congress Presentation
Absence of late gadolinium enhancement and outcomes of cardiac resynchronization therapy in non-ischemic dilated cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources